Early pregnancy screening to reduce complications after high blood pressure
Part of Women’s health & pregnancy clinical trials.
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be pregnant and between 11 and 14 weeks (no earlier than 11, no later than 14)
- Be 18 years of age or older
- Have health insurance coverage (including AME, if applicable)
- Sign an informed consent form to join the study
- Not have an ectopic pregnancy or a pregnancy that is not continuing
- Not have twins or more (multiple pregnancy) and no known major baby birth defect found at early ultrasound
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
This study aims to prevent preeclampsia, a serious pregnancy condition that can cause high blood pressure and other complications. Researchers will test a screening and prevention approach offered to pregnant women early in their first trimester to see if it helps reduce the risk.
This trial compares two doses of aspirin (75 mg vs 150 mg) in pregnant women at high risk for preeclampsia to see which dose works better to prevent the condition.
This study aims to see if a new blood test can help predict preeclampsia, a serious condition that can occur during pregnancy. It may help identify risk early so that you and your baby can receive the right care.
This study offers a combined screening test for pregnant women in their first trimester. It helps check for potential health issues early in pregnancy.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.